Your browser doesn't support javascript.
loading
EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report.
von Buttlar, Xinyu; Reuss, Joshua E; Liu, Stephen V; Kim, Chul.
Affiliation
  • von Buttlar X; MedStar Georgetown University Hospital, Department of Medicine, Washington, District of Columbia.
  • Reuss JE; MedStar Georgetown University Hospital, Department of Medicine, Washington, District of Columbia.
  • Liu SV; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
  • Kim C; MedStar Georgetown University Hospital, Department of Medicine, Washington, District of Columbia.
JTO Clin Res Rep ; 2(6): 100179, 2021 Jun.
Article in En | MEDLINE | ID: mdl-34590027
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JTO Clin Res Rep Year: 2021 Document type: Article